MTOR and Alzheimer disease: Furthermore, the FTO-induced hypo-m6A levels have been shown to activate the TSC1-mTOR-Tau signaling pathway and increased apoptosis of dopaminergic neurons, which contributes to the pathogenesis of Alzheimer’s disease (AD) and Parkinson’s disease (PD), respectively [278,279,280].